...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis, characterization, antiproliferative and anti-metastatic properties of two ruthenium-DMSO complexes containing 2,2'-biimidazole.
【24h】

Synthesis, characterization, antiproliferative and anti-metastatic properties of two ruthenium-DMSO complexes containing 2,2'-biimidazole.

机译:两种含2,2'-联咪唑的钌-DMSO配合物的合成,表征,抗增殖和抗转移特性。

获取原文
获取原文并翻译 | 示例
           

摘要

Two new ruthenium complexes, trans,cis,cis-[RuCl2(DMSO)2(H2biim)] (1) and mer-[RuCl3(DMSO)(H2biim)] (2) (DMSO=dimethyl sulfoxide and H2biim=2,2'-biimidazole), have been synthesized and fully characterized by single-crystal X-ray analysis. The less stable complex 2 is more cytotoxic against the four human cancer cell lines tested than 1. Further studies show that 1 and 2 exhibit cell growth inhibition by triggering G0/G1 cell cycle arrest and mitochondria-mediated apoptosis. Additionally, complex 2 exerts potent inhibitory effects on the adhesion and migration of human cancer cells comparable to that of NAMI-A ([ImH][trans-[RuCl4(Im)(DMSO-S)], Im=imidazole). Target validation studies show that cyclin-dependent kinases (CDKs), other than DNA, are more likely to be targets of 1 and 2.
机译:两种新的钌络合物,反式,顺式,顺式-[RuCl2(DMSO)2(H2biim)](1)和mer- [RuCl3(DMSO)(H2biim)](2)(DMSO =二甲基亚砜,H2biim = 2,2 '-biimidazole)已合成,并通过单晶X射线分析进行了全面表征。较不稳定的复合物2对四种测试的人类癌细胞系的毒性更高。进一步的研究表明1和2通过触发G0 / G1细胞周期停滞和线粒体介导的凋亡而表现出细胞生长抑制作用。另外,与NAMI-A([ImH] [反式-[RuCl4(Im)(DMSO-S)],Im =咪唑)相比,复合物2对人癌细胞的粘附和迁移具有强大的抑制作用。靶标验证研究表明,除DNA外,细胞周期蛋白依赖性激酶(CDK)更可能是1和2的靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号